Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.9 Billion CNY | -32.58% |
| 2022 | 2.82 Billion CNY | 6.34% |
| 2021 | 2.65 Billion CNY | -10.6% |
| 2020 | 2.96 Billion CNY | 5910.3% |
| 2019 | 49.4 Million CNY | 1991.74% |
| 2018 | 2.36 Million CNY | -84.2% |
| 2017 | 14.94 Million CNY | 326.27% |
| 2016 | 3.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.51 Billion CNY | 0.0% |
| 2024 Q1 | 1.51 Billion CNY | -20.59% |
| 2023 FY | 1.9 Billion CNY | -32.58% |
| 2023 Q1 | 2.9 Billion CNY | 2.77% |
| 2023 Q4 | 1.9 Billion CNY | 0.15% |
| 2023 Q3 | 1.9 Billion CNY | -34.58% |
| 2023 Q2 | 2.9 Billion CNY | 0.13% |
| 2022 Q4 | 2.82 Billion CNY | 0.08% |
| 2022 FY | 2.82 Billion CNY | 6.34% |
| 2022 Q3 | 2.82 Billion CNY | 0.39% |
| 2022 Q2 | 2.8 Billion CNY | 0.08% |
| 2022 Q1 | 2.8 Billion CNY | 5.75% |
| 2021 Q1 | 2.36 Billion CNY | -20.24% |
| 2021 Q3 | 2.64 Billion CNY | 11.35% |
| 2021 Q4 | 2.65 Billion CNY | 0.21% |
| 2021 FY | 2.65 Billion CNY | -10.6% |
| 2021 Q2 | 2.37 Billion CNY | 0.45% |
| 2020 Q3 | 2.95 Billion CNY | 414.71% |
| 2020 FY | 2.96 Billion CNY | 5910.3% |
| 2020 Q1 | 563.78 Million CNY | 1041.11% |
| 2020 Q4 | 2.96 Billion CNY | 0.39% |
| 2020 Q2 | 574.71 Million CNY | 1.94% |
| 2019 Q3 | 24.94 Million CNY | -53.88% |
| 2019 Q1 | 32.24 Million CNY | 1265.07% |
| 2019 FY | 49.4 Million CNY | 1991.74% |
| 2019 Q4 | 49.4 Million CNY | 98.03% |
| 2019 Q2 | 54.09 Million CNY | 67.79% |
| 2018 FY | 2.36 Million CNY | -84.2% |
| 2018 Q3 | 222.96 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q4 | 2.36 Million CNY | -98.94% |
| 2017 FY | 14.94 Million CNY | 326.27% |
| 2016 FY | 3.5 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -6293.685% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -301961.018% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -1553546.531% |
| Qrons Inc. | 351.84 Thousand USD | -540821.764% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -251580.367% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -4288.023% |
| BioStem Technologies, Inc. | 4.71 Million USD | -40295.851% |
| Skye Bioscience, Inc. | 4.61 Million USD | -41137.428% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | 310 Thousand USD | -613840.968% |
| CSL Limited | 12.18 Billion USD | 84.378% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -4077.386% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -9262.539% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -7399942.77% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -32316.757% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -4519.122% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -46072.655% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -473514.965% |
| SQZ Biotechnologies Company | 27.47 Million USD | -6828.095% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -81725.186% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -200603.913% |
| Mesoblast Limited | 118.7 Million USD | -1503.379% |
| Marizyme, Inc. | 18.71 Million USD | -10068.119% |
| Genus plc | 233.1 Million USD | -716.481% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -64847.611% |
| Pharming Group N.V. | 171.54 Million USD | -1009.456% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -214210.793% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -141552.252% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -253662.267% |
| ContraFect Corporation | 2.88 Million USD | -65960.986% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -1404622.962% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -131490.403% |
| IMV Inc. | 28.88 Million USD | -6489.197% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -33535.53% |
| MultiCell Technologies, Inc. | 202.58 USD | -939488990.73% |
| ONE Bio Corp. | 19.71 Million USD | -9553.639% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -3210.576% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -127226.692% |
| Q BioMed Inc. | 4.1 Million USD | -46207.197% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -5649.727% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -154839.55% |
| Biomind Labs Inc. | 735.54 Thousand USD | -258650.282% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -2713.626% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -62791.503% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -14543.516% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -528997.606% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -1344758.605% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -84173.513% |
| GB Sciences, Inc. | 1.75 Million USD | -108079.925% |
| Alpha Cognition Inc. | 1.22 Million USD | -155853.84% |
| HST Global, Inc. | 98.31 Thousand USD | -1935657.076% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -765104.648% |
| Halberd Corporation | 150 Thousand USD | -1268711.333% |
| Enzolytics Inc. | 996.33 Thousand USD | -190921.22% |
| Agentix Corp. | 50 Thousand USD | -3806334.0% |
| Resverlogix Corp. | 6.49 Million USD | -29220.86% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -744530.896% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -9416.085% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -26808.923% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -70163.037% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -18613269.193% |
| Genscript Biotech Corporation | 417.73 Million USD | -355.6% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -948586.545% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -79275.983% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -829944.354% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1280199.891% |
| Kadimastem Ltd | 891.22 Thousand USD | -213450.435% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -760632.986% |
| LadRx Corporation | 33.6 Thousand USD | -5663225.001% |
| Cell Source, Inc. | 9.25 Million USD | -20466.039% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -251580.367% |
| NovAccess Global Inc. | 2.19 Million USD | -86414.583% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -833266.32% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -902005.463% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -38094.2% |
| Mobile Lads Corp. | 484.28 Thousand USD | -392896.052% |
| CytoDyn Inc. | 30.07 Million USD | -6228.026% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -24237.938% |
| SYBLEU INC | 477.5 Thousand USD | -398479.476% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -40092.263% |
| International Stem Cell Corporation | 4.17 Million USD | -45453.303% |
| Bioxytran, Inc. | 1.92 Million USD | -98768.416% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -3049291.954% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -87167.504% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -22786.207% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -22069.097% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -122255.686% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -710055.597% |
| Neutra Corp. | 54.15 Thousand USD | -3514223.436% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -103900.929% |
| PureTech Health plc | 25.51 Million USD | -7360.085% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -155362.88% |
| IXICO plc | 472.02 Thousand USD | -403104.293% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -12178.027% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -2956.738% |
| CSL Limited | 12.18 Billion USD | 84.378% |
| Cellectis S.A. | 92.77 Million USD | -1951.4% |